Summary: Fifty-two surviving low-birth-weight infants who had low Thrombotest (Owren) results on the first day, together with the same number of matched controls with higher Thrombotest results, were examined for the integrity of their central nervous system. Gross abnormalities were found in 13.5% of the low Thrombotest group compared with 1.9% in the higher group.
Introduction
Infants of low birth rate who have a severe prothrombin complex deficiency on the first day of life are more likely to die with intracranial haemorrhage than those with a better coagulation status. Fourteen per cent of low-birth-weight infants with low prothrombin complex levels on the first day, as measured by the Thrombotest (Owren), died with cerebral haemorrhage, compared with 5'S,% of those with higher Thrombotest levels (over 10%/,) (Gray et al., 1968) . Not all babies with cerebral haemorrhage die, and so it is to be expected that the surviving infants who had a diminished clotting status at birth, and were therefore at risk of cerebral haemorrhage, would show an increased incidence of brain damage. To test this hypothesis we investigated survivors who had a Thrombotest level of 10%/, and less on the first day of life, along with carefully matched controls.
Subjects and Methods
Fifty-two infants in the low Thrombotest group were matched with an equal number of controls who had a Thrombotest greater than 10%. The babies, who were born in the years 1965, 1966, and 1967 , were matched for birth weight, date of birth within three months, gestation within four weeks, twinning, type of delivery, complications of pregnancy, and the presence or absence of placental insufficiency (Table I) . Other factors which have been noted to be closely associated with a low Thrombotest (Gray et al., I968) were also matched wherever possible. These are hypoglycaemia, hypoxia during birth, and the Apgar score. A subgroup who had formal intelligence tests were matched also for social class. The method and timing of the Thrombotest estimations were as described previously (Gray et al., 1968 (Sheridan, 1960a) Table II ). Findings Gross Abnormalities.-Seven children in the low Thrombotest group had gross central nervous system abnormalities (13.5% of the total). By contrast only 1 of the 52 babies (1-9%) with a Thrombotest above 10% had similar findings (see Table III ). The difference is significant at P=0.03. In addition to this group of children with gross abnormalities there were five children in the low Thrombotest group and one particular field of development who had one or more features of minor brain damage-qnamely, clumsy movements associated with minor abnormalities of gait, a speech defect, and a squint. Some children had a lower general developmental score (G.Q.) than that which was appropriate to the The matching was imperfect in the group of children who had blood glucose results of less than 20 mg./100 ml. on one or more occasions in the first two days of life. Hypoglycaemia may be an important factor in the aetiology of brain damage, and so the babies who had hypoglycaemia were analysed separately (Table V) . Only two who were severely affected had hypoglycaemia. The other six had normal glucose levels, and the distribution of these-five in the low Thrombotest group to one in the control group-is significant at P=0-045. Ruth Griffiths score thrombotest <I9o-f thrombotest > 10%Po
Intelligence quotients of the two groups when grossly abnormal infants and their controls have been omitted.
There were three with slight brain damage who were hypoglycaemic and had a low Thrombotest compared with two with hypoglycaemia in the higher Thrombotest group. These figures, therefore, show that hypoglycaemia did not play an appreciable part in the aetiology of these children's abnormalities.
Discussion
The results show the less favourable prognosis to be expected with a low Thrombotest on the first day of life. In addition to increased likelihood of death with intracranial haemorrhage there is the increased hazard of survival with brain damage. There are at least two possible explanations for this. Firstly, the original hypothesis of the diminished coagulability of the blood may lead to a cerebral haemorrhage which is not fatal. This was proved in only one of the babies by lumbar puncture, normally done in this unit only when there is a suspicion of meningitis. Secondly, the mechanism may be that of disseminated intravascular coagulation causing fibrin deposition in the end arteries of the brain. Boyd (1967) Appleyard (1968) showed that babies born after an anoxic delivery developed a significant lowering of the Thrombotest at 24 hours compared with those who were not anoxic during delivery. Possibly the lowered Thrombotest is associated with liver damage due to hypoxia; however, more probably the infants had some degree of disseminated intravascular coagulation resulting from the metabolic acidosis and hypotension associated with intrapartum asphyxia. The intravascular coagulation reduces clotting factors-including prothrombin (factor II), which is consumed-and this will be reflected by a lowered Thrombotest. Some intravascular coagulation undoubtedly occurs in anoxic babies during delivery, as fibrin split products are almost invariably found in the first day of life (M. A. Chadd and S. M. Muxworthy, personal communication). It is suggested that this may be the mechanism in some of the present series. We have several times encountered babies with low Thrombotest who have responded to a dose of fresh frozen plasma by a rise in Thrombotest, but the level has quickly dropped. Some of these babies have shown no sign of haemorrhage at necropsy, so that the rapid drop in factor II level can be explained only by a consumption coagulopathy. The fibrin formed during coagulation, if deposited in small end arteries throughout the brain, could cause multiple areas of cerebral ischaemia, which may explain some of our findings.
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Introduction
Though kidney transplantation is now widely undertaken for certain patients with end-stage kidney disease, rejection and its sequelae continue to be major problems (Hume et al., 1966) . Rejections are common during the first three months after transplantation and require large doses of immunosuppressive drugs for their control (Lee et al., 1967) . As a result serious complications, including death of the patient, often develop in relation to a rejection episode (Starzl, 1964) . In general, rejections tend to be less severe and fewer in recipients of bettermatched than in recipients of poorly-matched kidneys (Terasaki et al., 1967) . At present HL-A matching is most precise and reliable in the selection of those sibling pairs who inherit the same HL-A chromosome from each of the parents and therefore have an identical HL-A genotype (Amos and Zmijewski, 1967 (Tilncy et al., 1970) were independent of the tissue match. Rejection episodes were treated with short courses of 200-400 mg. of prednisone which were rapidly tapered according to the response. A three-day course of actinomycin C was added in cases that responded poorly to prednisone.
Tissue typing was performed according to the microlymphocytotoxicity method of Terasaki and McClelland (1964) , with allogeneic anti-HL-A typing sera kindly supplied by Dr. Paul Terasaki, of Los Angeles, California. Thirtythree patients were typed for 12-18 and four for 8 leucocyte antigens. Of the latter patients three died and one was living overseas, so that they could not be retyped with a larger panel of typing sera. At the initial typing, however, two of these patients were considered incompatible with their donors for the leucocyte antigen HL-A2, which even in earlier typings was the most accurately defined of all leucocyte antigens (Patel et al., 1969) . A third patient was identical with his donor for three antigens as well as for a number of unspecified sera. Thus despite the fact that typings were done at different periods their accuracy is likely to be seriously questioned in only one of the 37 patients in this series. On the basis of the results of leucocyte typing, the following histocompatibility grades were assigned: recipient-
